Gerresheimer Presents Strong Results for Financial Year 2013

Gerresheimer Presents Strong Results forGerresheimer Presents Strong Results for Financial Year 2013 PR Newswire DUSSELDORF, Germany, February 13, 2014 • Revenues up 3.8%, at constant exchange rates up 5.8%, to EUR 1,265.9m • Adjusted EBITDA gains 4.1% on prior year, totaling EUR 249.8m, EUR 254.0m at constant exchange rates • Adjusted earnings per share rise by 17.6% to EUR 3.08 • Capital market guidance met in full • Proposed dividend: EUR 0.70 per share (prior year: EUR 0.65 per share) • Targeted investment the key to success Cross reference: The full press release including tables is available at: http://www.presseportal.de/pm/9072/gerresheimer-ag?keygroup=dokument Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, brought financial year 2013 to a successful close. "2013 was a rewarding year for us.We met all the targets we set ourselves. At the beginning of financial year 2014, we sharpened our organization's customer focus. We are investing in highly promising growth projects, further improvements in quality and the internationalization of our business. These are important steps in setting the course for our future," said Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG. Gerresheimer increased revenues in financial year 2013 (December 1, 2012 to November 30, 2013) by 3.8% to EUR 1,265.9m. At constant exchange rates, this corresponds to growth of 5.8%.